Notice

We use cookies to constantly improve our internet content and to create internal assessments pursuant to our data protection guidelines.

Further information

OK

LINC 2019 presentations


LINC 2019, the Leipzig Interventional Course,  featured state-of-the-art lectures and numerous live cases have been performed from leading interventional centers.

LINC 2019 took place from Tuesday, 22 January through Friday, 25 January 2019.

Cookie notice
In order to use the Issuu PDF reader, you will have to consent to the use of cookies categorized under "External Services".
Open cookie settings

LINC 2019 programme

Find all topics and speakers listed below.

Conference day 1

  • - , Room 1 - Main Arena 1

    Symposium: Keep on walking: Steps towards successfull PAD treatment

    Moderator:
    Dierk Scheinert
    Panel:
    Thomas Zeller, Jonathan Sobocinski, Koen Deloose, Jörg Teßarek, Shannon Thomas
    1. -

      Step by step SFA/pop treatment algorithm

        Thomas Zeller
    2. -

      Step by step selection algorithm and clinical decision making through OCT technology

        Jonathan Sobocinski
    3. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    4. -

      Supera CFA VMI 1-year follow-up results

        Koen Deloose
    5. -

      Supera in AVF management and 1-year outcomes

        Shannon Thomas
    6. -

      Supera in popliteal aneurysm, proof of concept, and clinical outcomes

        Jörg Teßarek
    7. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
  • - , Room 2 - Main Arena 2

    Acute deep vein thrombosis

    Moderator:
    Rick de Graaf, Michael Lichtenberg
    Panel:
    Stephen Black, Houman Jalaie, Olivier Hartung, Tim Sebastian
    1. -

      Ascending femoropopliteal DVT without iliac vein involvement: any role for endovascular therapy

        Olivier Hartung
    2. -

      Ultrasound-assisted thrombolysis for acute DVT: effect of ultrasound waves and microbubbles on thrombus removal

        Rolf Engelberger, Via satellite from Zurich
    3. -

      The CAVA study, what can we expect?

        Houman Jalaie
    4. -

      Evidence for endovascular therapy of iliofemoral DVT: CAVENT, ATTRACT, CAVA, uncontrolled studies

        Stephen Black
    5. -

      Anticoagulation therapy following endovascular therapy of iliofemoral DVT

        Tim Sebastian
    6. -

      Live case transmission from Zurich

        UniversitätsSpital Zürich - Live case center
    7. -

      Live case transmission from Galway

        Galway University Hospital - Live case center
  • - , Room 3 - Technical Forum

    Management of carotid artery disease: Remaining controversies, latest technologies, and challenges ahead

    Moderator:
    Horst Sievert, Alison Halliday
    Panel:
    Martin Storck, Giancarlo Biamino, Frank Veith
    1. -

      Assessment of carotid plaque morphology using photoacoustic imaging

        Marc van Sambeek
    2. -

      LINC status update: Management of asymptomatic stenose: Medical therapy is usually sufficient for asymptomatic carotid stenosis. What are the exceptions?

        Johann Pelz
    3. -

      LINC status update: Management of asymptomatic stenose: Carotid repair is best for asymptomatic carotid stenosis because medical management alone does not work

        Peter Schneider
    4. -

      Status update on the ongoing trials looking at asymptomatic carotid stenoses

        Alison Halliday
    5. -

      Audience vote

    6. -

      Live case transmission from Berlin

        Sankt-Gertrauden-Hospital Berlin - Live case center
    7. -

      Carotid interventions – is there a gender difference in outcome?

        Martin Storck
    8. -

      40 years of carotid angioplasty – A glance back

        Klaus Mathias
    9. -

      LINC status update: Is carotid stenting largely equivalent to carotid endartherectomy for the majority of patients with significant carotid disease and indication for revascularisation? What are the open questions?

        William Gray, Frank Veith
    10. -

      1-year results of the SCAFFOLD study: GORE PTFE mesh-covered carotid stent

        Peter Schneider
    11. -

      Parameters affecting the risk of embolization during carotid stenting

        Peter Huppert
    12. -

      Initial clinical study of the new CGuard™ MicroNet®covered carotid-stent: One size fits all – experimental data and clinical results

        Christian Wissgott
    13. -

      Dual layer stents for CAS: all you need to know to avoid acute re-occlusion

        Stefan Müller-Hülsbeck
    14. -

      Proximal protection during CAS: Why is it the superior concept?

        Giancarlo Biamino
    15. -

      TECAR with proximal flow reversal in symptomatic patients is superior to carotid endarterectomy no matter what kind of stent is used – results of a prospective study which includes DWMRI analysis

        Ralf Kolvenbach
    16. -

      Avoiding and managing complications during CAS – lessons learned

        Horst Sievert
    17. -

      Live case transmission from Bergamo

        Humanitas Gavazzeni Bergamo - Live case center
    18. -

      Audience vote

  • - , Room 1 - Main Arena 1

    Symposium: See clearly, treat optimally: image guided therapy on the rise

    Moderator:
    Dierk Scheinert, Frans Moll
    Panel:
    Constantino Peña, Jim A. Reekers, Fabrizio Fanelli, Maria Louisa Izamis
    1. -

      Introduction and learning objectives

        Dierk Scheinert
    2. -

      Next generation pan-vascular suite: optimizing patient management and outcomes

        Constantino Peña
    3. -

      Perfusion angiography for optimizing planning and treatment of diabetic foot

        Jim A. Reekers
    4. -

      BTK recorded case presentation

        Marco Manzi
    5. -

      Role of IVUS within a “treat optimally” algorithm of care

        Fabrizio Fanelli
    6. -

      Innovations at the forefront: a glance at the future of image guided therapy

        Maria Louisa Izamis
    7. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    8. -

      Q&A and conclusion

  • - , Room 2 - Main Arena 2

    Aorto iliac obstructive disease: Endoluminal solutions

    Moderator:
    Michele Antonello, Hans Krankenberg
    Panel:
    Koen Deloose, Patrice Mwipatayi, Gianmarco de Donato, Sean Lyden, Frank Vermassen
    1. -

      Complexity of iliac occlusive disease, current treatment algorithm, and treatment gaps

        Michele Antonello
    2. -

      Crossing techniques for complex aortoiliac obstructions – Why is the bi-directional approach the best?

        Andrej Schmidt
    3. -

      Self-expanding vs. balloon-expandable stents for iliac artery disease: Is either superior?

        Hans Krankenberg
    4. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    5. -

      The value of covered stents in treatment of complex TASC C and D iliac lesions: the initial experiences with the BELSTREAM study

        Koen Deloose
    6. -

      First time data release: The BOLSTER study with the Lifestream covered stent in iliac lesions – 3-year outcomes

        John Laird
    7. -

      Case discussion: Challenging bilateral iliac case treated with VBX

        Hany Zayed
    8. -

      Case discussion: Covered self-expandable endoprosthesis and dual component stent for iliac treatment

        Raffaello Bellosta
    9. -

      Case discussion: Aorto iliac case with covered balloon expandable stent

        Gianmarco de Donato
    10. -

      Discussion and conclusion

  • - , Room 5 - Global Expert Exchange

    CLI-Therapies-LINCed: Multidisciplinary case studies from centres of excellence. Tailored strategies on revascularisation and wound management

    Moderator:
    Steven Kum
    Panel:
    Yann Gouëffic, Yoshimitsu Soga, Marco Manzi, Roberto Ferraresi

    1. MANAGING THE INFECTED WOUND

    2. -

      Case presentation: How do I combine wound care with revascularisation?

        Roberto Ferraresi
    3. -

      Question and answers

    4. MULTI-VESSEL OR SINGLE VESSEL REVASCULARISATION

    5. -

      Case presentation: Why I chose multi vessel revascularisation

        Yoshimitsu Soga
    6. -

      Question and answers

    7. SIMULTANEOUS REVASCULARISATION AND WOUND CARE

    8. -

      Case presentation: Revascularisation and wound care under a nerve block – How to do it

        Steven Kum
    9. -

      Question and answers

    10. OPTIMIZING THE “IN-FLOW” IN CLI

    11. -

      Case presentation: The use of DES in CLI

        Yann Gouëffic
    12. -

      Question and answers

    13. SOLUTIONS FOR POOR “OUTFLOW”

    14. -

      Case presentation: LimFlow procedure for no-option CLI

        Michiel Schreve
    15. -

      Question and answers

    16. -

      Panel round-up

  • - , Room 1 - Main Arena 1

    Long-term safety of drug-eluting technologies in the leg – recent findings, controversies, and future outlook

    Moderator:
    Dierk Scheinert, John Laird
    Panel:
    Konstantinos Katsanos, Peter Schneider, Michael Dake, Thomas Zeller, William Gray, Sean Lyden
    1. -

      Risk of death following application of Paclitaxel-coated balloons and stents in the femoropopliteal artery – findings from a metaanalysis of RCTs

        Konstantinos Katsanos
    2. -

      A look into the methods: merits and limits of meta-analysis

        Timothy Hanson
    3. -

      Toxicological aspects and safety profile of Paclitaxel

        Juan Fernando Granada Solis
    4. -

      Event adjudication in clinical trials: how does it work?

        Marc van Sambeek

    5. PATIENT LEVEL DATA FROM MAJOR CLINICAL TRIAL PROGRAMMES WITH DRUG-ELUTING DEVICES

    6. -

      DCBs over the long-term: Are they safe for our PAD patients? Insights from the In.Pact DCB programme

        Peter Schneider
    7. -

      Long-term safety data of the Lutonix DCB formulation

        Dierk Scheinert
    8. -

      Long-term safety data from the Stellarex DCB programme

        Sean Lyden
    9. -

      Long-term safety information on Paclitaxel eluting stents – insights from the Zilver PTX programme

        Michael Dake
    10. -

      Patient safety in the Eluvia-DES and Ranger DCB programme

        William Gray
    11. -

      How to proceed to generate more evidence on patient safety with drug-eluting devices

        Peter Schneider
    12. -

      Podium discussion

  • - , Room 2 - Main Arena 2

    Venous stent placement for post-thrombotic syndrome

    Moderator:
    Houman Jalaie, Stephen Black
    Panel:
    Robert Lookstein, Mahmood Razavi, Ramon Varcoe, Oliver Schlager
    1. -

      VENOVO® venous stent – 12-month update on the Vernacular trial

        Michael Dake
    2. -

      Live case transmission from Zurich

        UniversitätsSpital Zürich - Live case center
    3. -

      Live case transmission from Galway

        Galway University Hospital - Live case center
    4. -

      Update on performance of venous stents for PTS patients

        Michael Lichtenberg
    5. -

      First time data release: VIRTUS trial: Pivotal cohort 12-month primary safety and efficacy results of the Vici venous stent system

        Mahmood Razavi
    6. -

      IVUS and pressure gradients for PTS treatment: mandatory or fancy?

        Rick de Graaf
    7. -

      Live case transmission from Zurich

        UniversitätsSpital Zürich - Live case center
    8. -

      Live case transmission from Galway

        Galway University Hospital - Live case center
  • - , Room 3 - Technical Forum

    Focus session: Advances in stroke management

    Moderator:
    Franziska Dorn, Hans Henkes
    Panel:
    Stephan Duda, Marios Nikos Psychogios
    1. -

      The art of thrombectomy

        Hans Henkes
    2. -

      Stroke treatment: New data

        Franziska Dorn
    3. -

      Time management in endovascular stroke treatment

        Marios Nikos Psychogios
    4. -

      Credentialing approaches for interventional stroke management

        Stephan Duda
    5. -

      Discussion and conclusion

  • - , Room 1 - Main Arena 1

    “To stent or not to stent?” – Latest data on stentless and stent-based treatment approaches for femoropopliteal lesions

    Moderator:
    Dierk Scheinert, William Gray
    Panel:
    Osamu Iida, Gunnar Tepe, Hiroyoshi Yokoi

    1. FOCUS ON NEW DATA ON DRUG-COATED BALLOONS

    2. -

      First time data release: Randomized trial of DCB vs. PTA: Final 3-year clinical outcomes from IN.PACT Japan

        Osamu Iida
    3. -

      First time data release: Insights from the IN.PACT global study 3-year data: Does lesion complexity affect results?

        Jos van den Berg
    4. -

      First time data release: Global diabetic analyses of all Lutonix DCB SFA combined trials

        Koen Deloose
    5. -

      First time data release: COMPARE-Pilot RCT: 2-year results of a randomized comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

        Dierk Scheinert
    6. -

      First time data release: IN.PACT Global study 3-year outcomes for stented vs. non-stented lesions

        Thomas Zeller
    7. -

      First time data release: Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries: 24-month results of the BIOLUX P-III full cohort

        Gunnar Tepe
    8. -

      DCB in severe Calcium: Core-laboratory analysis and perspectives from the ILLUMENATE trial series

        Sean Lyden
    9. -

      Stellarex in real world: Interim look from the SAVER registry

        Frank Vermassen

    10. FOCUS ON NEW DATA ON DRUG-ELUTING STENTS AND DCB/IMPLANT COMBINATIONS

    11. -

      First time data release: Final 12-month results of the Zilverpass-RCT of Zilver PTX vs. bypass

        Marc Bosiers
    12. -

      TOBA II Trial (Lutonix or POBA + Tack) – 1-year results

        William Gray
    13. -

      First time data release: Diabetic patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

        Stefan Müller-Hülsbeck
    14. -

      First time data release: Japanese patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents

        Osamu Iida
    15. -

      First time data release: Zilver PTX Japan 5-year results for paclitaxel-eluting stent treatment of femoropopliteal artery disease

        Hiroyoshi Yokoi
    16. -

      The Illumina FIH study with a next generation DES – 12-month results

        Dierk Scheinert
    17. -

      Discussion and conclusion

  • - , Room 2 - Main Arena 2

    Lunch symposium: Treating PAD in the SFA: “Challenge the status quo” – Revealing new evidence to provide the answers

    Moderator:
    Michael Dake
    Panel:
    Marc Bosiers, Iris Baumgartner-Peuker, Robert Beasley
    1. -

      Introduction

        Michael Dake
    2. -

      Zilver PTX Global data analysis highlights DES benefits in challenging patient populations

        Michael Dake
    3. -

      Tried and True: Evaluating the momentary hype

        Robert Beasley
    4. -

      Follow the data: Your 2019 treatment algorithm

        Iris Baumgartner-Peuker
    5. -

      Zilver PTX vs. Bypass: One year results: ZILVERPASS

        Marc Bosiers
    6. -

      Summary of symposium, discussion, and debate

        Michael Dake
  • - , Room 4 - Discussion Forum

    How guidewire technology can influence procedural outcome in different approaches

    Moderator:
    Jos van den Berg

    1. Different guidewire construction

        Jos van den Berg

    2. SFA lesions guidewire selection

        Koen Deloose

    3. POP-BTK lesions guidewire selection

        Roberto Ferraresi

    4. POP-BTK lesions guidewire selection

        Daniel Périard

    5. Table discussion & closing remarks from moderator

        Jos van den Berg
  • - , Room 6 - Speakers' corner

    Update on clinical trials and new data – PVD/BTK/CLI

    Moderator:
    Jihad Mustapha
    Panel:
    Matthew Menard, Miguel Montero-Baker
    1. -

      Magnesium resorbable drug-eluting scaffold (Magmaris) for below the knee recanalisation: 12-month follow-up analysis

        Daniel Périard
    2. -

      Clinical effectiveness of the absorb bioresorbable vascular scaffold in patients with complex infrapopliteal arterial disease

        Atman Shah
    3. -

      24-month outcomes of patients presenting with critical limb ischemia within the BIOLUX P-III registry – a real-world clinical trial treating atheriosclerotic arteries with a paclitaxel covered balloon

        Marianne Brodmann
    4. -

      Angioplasty and stenting versus bypass graft surgery for the treatment of simultaneous femoropopliteal and infrapopliteal complex (TASC C or D) arterial disease in patients with critical limb ischemia

        Ivan Casella
    5. -

      Impact of endovascular pedal arch reconstruction on wound healing in patients with critical limb ischemia

        Young-Guk Ko
    6. -

      Discussion

  • - , Room 7 - Speakers' corner

    Selected abstracts original research – EVAR (part I)

    Moderator:
    Konstantinos Donas
    Panel:
    Sven Seifert, Thomas Larzon
    1. -

      Open thoracic and thoraco-abdominal aortic repair after prior endovascular therapy

        Drosos Kotelis
    2. -

      The evolving management of ruptured abdominal aortic aneurysms: An Australasian experience

        Cindy Wang
    3. -

      Results of Chimney EVAR as used in the PERICLES registry to treat patients with suprarenal aortic pathologies

        Gergana T. Taneva
    4. -

      Prevention of Type II endoleak: role of EVAS technique in comparison to sac embolization technique in case of abdominal aortic aneurysm treatment

        Paola Scrivere
    5. -

      Systematic multi-staged endovascular repair of thoracoabdominal aneurysms with fenestrated and branched endografts (STEAR study)

        Diletta Loschi
    6. -

      Screening Cardiovascular patients for Aortic aNeurysms (SCAN) – High prevalence of AAA in CHD requiring intervention

        Benedikt Reutersberg
    7. -

      Hypogastric revascularisation during EVAR: surgical and endovascular techniques. Single centre experience

        Ilaria Ficarelli
    8. -

      The subclavian artery access for difficult vascular interventions

        Enrique Alejandre Lafont
    9. -

      Impact of post-EVAR graft limb kinking in EVARlimb occlusion – etiology, early diagnosis, and management

        Andreia Coelho
    10. -

      Discussion

  • - , Room 3 - Technical Forum

    Lunch symposium: Why do we need proven balloon expandable covered stents for long term performance?

    Moderator:
    Eric Ducasse
    Panel:
    Eric Verhoeven, Giovanni Torsello
    1. -

      The 15-year evolution of covered stent: Choosing the best stent for iliac artery disease. Is COBEST a strong evidence for V12 as choice of covered stent?

        Patrice Mwipatayi
    2. -

      Reliable performance of Advanta V12 in complex aortic cases as a renal stent

        Eric Verhoeven
    3. -

      Long-term Münster experience with Advanta V12 and latest in-vitro evidence

        Giovanni Torsello
    4. -

      Discussion and conclusion

  • - , Scientific Posters

    Challenging cases: Iliac, venous

    Juror:
    Houman Jalaie, Stephen Black
    1. -

      The challenging procedure of complex AIOD with newly iliac covered stent

        Masahiko Fujihara
    2. -

      Successful endovascular treatment of a rigid patient with Leriche syndrome

        Bor-Hsin Jong
    3. -

      Successful hybrid revascularisation in TASC D AIOD aortic occlusion plus bilateral iliac artery occlusion by applying CERAB concept

        Jaroen Cheewinmethasiri
    4. -

      Primary stenting for chronically occluded abdominal aorta in a high-risk patient

        Marcel Voos Budal Arins
    5. -

      Open repair of asymtomatic iliac pseudoaneurysm: a late complication after of the implantation of common iliac artery stent

        Nancy Marisela Coraizaca Chicaiza
    6. -

      “Crush Stenting” a new approach to treat occluded iliac stent

        Melek Ben Mrad
    7. -

      Endovascular treatment of a iatrogenic iliac arteriovenous fistula

        Giuseppe D'Arrigo
    8. -

      Compression of the left common iliac vein by the right common iliac artery at the end of gestation

        Josualdo Silva
    9. -

      Successful single session treatment of massive left-side iliofemoral deep vein thrombosis in May-Thurner syndrome

        Jun-Won Lee
    10. -

      Popliteal vein compression .... is it a main cause of DVT?

        Mohamed Nagib
    11. -

      Stenosis of the brachiocephalic vein and percutaneous thoracic thrombectomy with Thrombectomy system– case report

        Ewa Swiecka
    12. -

      Giant femoral artery pseudoaneurysm associated with arteriovenous fistula following shotgun injury with multiple complications

        Abbas Sarookhani
    13. -

      Endovascular recanalisation of extensive chronic total femoro-ilio-caval occlusion in a persistent bilateral venous ulcers

        Osman Mahmoud
    14. -

      Combined role of endovenous laser ablation, inj.ethanol embolisation & foam sclerotherapy in the treatment of congenital venous malformations (K-T Syndrome) cases

        Mangesh Tarte
    15. -

      Early results of venous stenting when there are no healthy landing zones in thrombophilic patient

        Ashraf Elnaggar
    16. -

      May Thurner syndrome and left labial varices

        Nasser Algharem
    17. -

      The role of 3D venous angiography and IVUS in diagnostic and treatment decision in May Thurner syndrome

        Simone Franco
    18. -

      Sudden rapid progressive venous gangrene in upper limb with 2 years well functioning AV access

        Ehab Elashaal
    19. -

      Endovascular treatment of post thrombotic syndrome in the left inferior vena cava

        Isabela Tavares
    20. -

      A successful intervention for venous thrombosis and pulmonary embolization with anti-thrombin deficiency

        Hirokazu Miyashita
    21. -

      Iliofemoral venous stenting for patients with chronic post-thrombotic venous occlusive disease

        Abdulrahman Salem
  • - , Room 1 - Main Arena 1

    Symposium: Strategies and innovative solutions for success in complex peripheral arterial disease

    Moderator:
    Dierk Scheinert
    Panel:
    John Laird, Theodosios Bisdas, Konstantinos Stavroulakis, Jos van den Berg
    1. -

      Endovascular lessons learned in the last decade: what are the remaining challenges?

        Theodosios Bisdas
    2. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    3. -

      Long lesions: primary stenting or DCB first?

        John Laird
    4. -

      Calcium: The Achilles heel of endovascular? Scaffold or remove before drug delivery?

        Konstantinos Stavroulakis
    5. -

      Live case transmission from New York

        Mount Sinai Hospital New York - Live case center
    6. -

      Dissections: prevent, minimize, or repair

        Jos van den Berg
    7. -

      Discussion and conclusion

  • - , Room 2 - Main Arena 2

    New concepts for AV-shunt revascularisation and central vein stenoses

    Moderator:
    Robert Lookstein, Ramon Varcoe
    Panel:
    Jernej Lučev, Scott Trerotola, Panagiotis Kitrou, Konstantinos Katsanos, Robert Jones
    1. -

      Endovascular treatment of haemodialysis arteriovenous fistula

        Jernej Lučev
    2. -

      COVERA™ – 6-month update on AVeNEW trial design for outflow stenosis in AV fistula circuits

        Bart Dolmatch
    3. -

      Effectiveness of stent-grafts for the treatment of central venous disease in haemodialysis patients with functioning arteriovenous (AV) fistulas

        Robert Jones
    4. -

      Live case transmission from Galway

        Galway University Hospital - Live case center
    5. -

      First time data release: IN.PACT AV access drug-coated balloon study: Full baseline characteristics

        Robert Lookstein
    6. -

      First time data release: 24-month results from LUTONIX AV randomized IDE trial

        Scott Trerotola
    7. -

      First time data release: Final 6-month results from the LUTONIX® Global AV registry

        Panagiotis Kitrou
    8. -

      Presentation of recorded cases

        Panagiotis Kitrou
    9. -

      Singapore & Taiwan experience with the Lutonix DCB in the AV registry

        Tze Tec Chong
    10. -

      First time data release: 4Fr WavelinQ EndoAVF system latest 6-month clinical outcomes

        Robert Jones
    11. -

      Recorded case presentation

        Scott Trerotola
    12. -

      Discussion and conclusion

  • - , Room 3 - Technical Forum

    Scrub-in with the experts: Innovative approaches for complex femoropopliteal lesions

    live from Berlin:
    Ralf Langhoff
    live from Leipzig:
    Sven Bräunlich
    Moderator:
    Luis Mariano Palena, Brian DeRubertis
    Panel:
    Klaus Amendt, Michael Lichtenberg, Chris Metzger

    1. Flash presentation: Treatment algorithm for a “leaving as little as possible behind” strategy in femoro-popliteal lesions

        Thomas Zeller

    2. Dissecting the TOBA Data: What does it mean in practice

        Peter Schneider

    3. INDICATIONS FOR SPOT STENTING – WHERE TO PLACE SPOT STENTS?

    4. Case discussion: Major dissection treated with DCB and spot stents

        Michael Lichtenberg

    5. Case discussion: Calcified long femoro-popliteal lesions treated with DCB and spot stents

        Erwin Blessing

    6. Long-segment stenting with woven nitinol stents: the new endoluminal bypass managing

        Brian DeRubertis
  • - , Room 5 - Global Expert Exchange

    Latest advancements in diabetic patients: May drug elution technologies improve clinical outcome?

    Moderator:
    Roberto Ferraresi, Katja Mühlberg
    Panel:
    Marco Manzi, Giancarlo Biamino, Michael Edmonds, Eric Ducasse
    1. -

      Live case transmission from Bergamo

        Humanitas Gavazzeni Bergamo - Live case center
    2. -

      The distribution and management of peripheral arterial disease (PAD) in the diabetic patient with neuropathic (Charcot) arthropathy: a new paradigm of critical limb ischaemia in diabetes

        Michael Edmonds
    3. -

      Ischemia/infection/amputation: When, what, and how to intervene

        Roberto Ferraresi
    4. -

      Critical Limb Ischemia: time is crucial!

        Frank Vermassen
    5. -

      Endovascular intervention vs. open surgery: Pro/cons and boundaries

        Eric Ducasse

    6. FOCUS ON SFA

    7. -

      Current developments in drug eluting technologies for complex SFA treatment

        Stefan Müller-Hülsbeck
    8. -

      When should we use DCBs? Why?

        Gunnar Tepe
    9. -

      When should we use DESs? Why?

        Andrea Kahlberg

    10. FOCUS ON BTK

    11. -

      Which revascularisation strategy for BTK disease in DM patients? Wound-related or total treatment?

        Steven Kum
    12. -

      When should we use DCBs? Why?

        Francesco Liistro
    13. -

      When should we use DESs? Why?

        Marco Manzi
    14. -

      Live case transmission from Berlin

        Sankt-Gertrauden-Hospital Berlin - Live case center
  • - , Room 6 - Speakers' corner

    Update on clinical trials and new data – PVD/SFA

    Moderator:
    Iris Baumgartner-Peuker
    Panel:
    William Gray
    1. -

      Peripheral CTO crossing with the SoundBite™ active wire

        Marianne Brodmann
    2. -

      Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenoses

        Marianne Brodmann
    3. -

      EffPac-Trial: Effectiveness of LUMINOR® DCB vs. POBA in the SFA: primary endpoint and 12-month results

        Ulf Teichgräber
    4. -

      Diabetic patients in a real-world clinical trial treated for peripheral arterial disease with a paclitaxel covered balloon. 24-month results of the BIOLUX P-III All Comers Registry

        Johannes Dahm
    5. -

      BEnefit of arterial preparation by LONGitudinal scoring before paclitaxel eluting balloon angioplasty of the superficial femoral and popliteal artery (The BELONG Study): recruitment status and early results

        Daniel Périard
    6. -

      Subgroup analyses of the CONSEQUENT randomized controlled trial investigating the clinical benefits of paclitaxel-resveratrol coated balloon angioplasty

        Thomas Albrecht
    7. -

      Outcome of DEB and PTA post stenting in occluded vs. stenotic lesions – subgroup analysis of the randomized Freeway Stent study

        Stefan Müller-Hülsbeck
    8. -

      Novel laser-based atherectomy catheter. Results from the Eximo Medical B-Laser™ IDE study

        Marianne Brodmann
    9. -

      24-month outcomes in the EVOLUTION study: Investigating the iVolution stent in femoropopliteal lesions

        Marc Bosiers
    10. -

      Bi-directional, self-expanding stent for superficial femoral artery lesions – 2-year interim-results from the Q3 registry

        Hans Krankenberg
    11. -

      A real world comparison of interwoven nitinol (Supera®) with drug-eluting stent (Zilver® PTX®) in patients with symptomatic femoro-popliteal stenosis

        Axel Haine
    12. -

      2-years results of a pilot prospective randomized study of the effect of dissection of the lamina vastoadductoria after stenting of the superficial femoral artery on the incidence of restenosis and stent fractures in TASC-II D lesions of the femoropopliteal arterial segment

        Artem Rabtsun
    13. -

      Results from the ENTRAP study: Lower extremity intervention using the Vanguard® IEP peripheral balloon angioplasty system with integrated embolic protection

        Thomas Zeller
    14. -

      Two year mortality post DEB and plain balloon angioplasty: pooled primary data analysis of 4 RCTs

        Thomas Albrecht
    15. -

      Discussion

  • - , Room 7 - Speakers' corner

    Selected abstracts original research – EVAR (part II)

    Moderator:
    Giovanni Torsello
    Panel:
    Spiridon Botsios
    1. -

      Aortic dilatation following Type B aortic dissection: a single-center retrospective study

        Hiu Fung Wong
    2. -

      Endovascular therapy for ischemic vs. non-ischemic complicated acute Type B aortic dissection (cATBAD)

        Ahmed Eleshra
    3. -

      New off-the-shelf FEVAR technique

        Bella Huasen
    4. -

      Feasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm

        Deokbi Hwang
    5. -

      Sequalae of EVAR limb occlusion, a 6-year retrospective review

        Terri-Ann Russell
    6. -

      Subclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair

        Simone Salvati
    7. -

      Totally percutaneous access for thoracic and thoracoabdominal endovascular aortic repair: upper extremity access

        Andrea Melloni
    8. -

      Low risk of spinal cord ischemia after endovascular repair for juxtarenal and thoracoabdominal aortic aneurysms using parallel stent graft implantation

        Reinhard Kopp
    9. -

      The Colt device – How cooperation with industry influenced the treatment of complex TAAAs

        Piotr Szopiński
    10. -

      “Soft” hybrid procedures in high risk patients – new view of aortic arch aneurysm treatment

        D. Chernova
    11. -

      TEVAR performed in 106 year old female; advantage of low profile Zenith Alpha thoracic endovascular graft

        Naoki Fujimura
    12. -

      Discussion

  • - , Room 4 - Discussion Forum

    Symposium: Are DCBs an effective treatment for SFA and BTK lesions?

    Moderator:
    Koen Deloose

    1. Best DCB outcomes in SFA TASC A&B lesions – EFFPAC-RCT 12-month follow-up

        Ulf Teichgräber

    2. DCB in SFA complex lesions. 1+1=3 – TINTIN trial first outcomes

        Koen Deloose

    3. State of the art of BTK vessel treatment

        Sebastian Sixt

    4. DCB is also a real option for BTK arteries – BIBLIOS presentation

        Wouter Lansink
  • - , Room 1 - Main Arena 1

    Symposium: Virtues of VIRTUS: Exploring implications for clinical practice

    Moderator:
    Stephen Black
    Panel:
    Mahmood Razavi, Michael Lichtenberg, Luis Izquierdo, Lowell Kabnick
    1. -

      Welcome and introduction

        Stephen Black
    2. -

      VIRTUS: Trial design and primary endpoint results

        Mahmood Razavi
    3. -

      VICI VENOUS STENT: Design attributes & patient outcome

        Lowell Kabnick
    4. -

      Panel discussion and questions

    5. -

      Complexities of chronic venous disease

        Michael Lichtenberg
    6. -

      Imaging, its central role in planning and guiding intervention

        Luis Izquierdo
    7. -

      Live case transmission from Galway

        Galway University Hospital - Live case center
    8. -

      Panel discussion and questions

  • - , Room 2 - Main Arena 2

    Symposium: Dual layer mircromesh – taking the latest technology to the next level

    Moderator:
    Giovanni Torsello
    Panel:
    Stefan Müller-Hülsbeck, Piero Montorsi, Torsten Fuß
    1. -

      How the Roadsaver stent changed my practice in CAS

        Stefan Müller-Hülsbeck
    2. -

      The impact of stent design and embolic protection on safety of CAS interventions

        Piero Montorsi
    3. -

      Live case transmission from Bergamo

        Humanitas Gavazzeni Bergamo - Live case center
    4. -

      My journey with Roadsaver through the last four years

        Piotr Odrowaz-Pieniazek
    5. -

      Latest experience with dual layer stents in the lower limbs

        Torsten Fuß
    6. -

      Live case transmission from Berlin

        Sankt-Gertrauden-Hospital Berlin - Live case center
  • - , Room 3 - Technical Forum

    Scrub in with the experts: Challenging aortoiliac interventions

    live from Leipzig:
    Andrej Schmidt
    live from New York:
    Prakash Krishnan
    Moderator:
    Lawrence Garcia, Michel Reijnen
    Panel:
    Patrice Mwipatayi, Sigrid Nikol, Hans Krankenberg

    1. Flash presentation: A series of BeGraft implantations in isolated aortic stenoses: a women’s issue?

        Sigrid Nikol

    2. Flash presentation: Acute and follow-up results of complete aortoiliac obstruction (Leriche syndrome) – The Leipzig experience

        Madeleine Luther

    3. Flash presentation: Global CERAB study: where are we standing?

        Michel Reijnen

    4. Flash presentation: Covered stents as a lifesaver for the patient and me in my most bizzare cases

        Maria Antonella Ruffino
  • - , Room 6 - Speakers' corner

    Update on clinical trials and new data – PVD/carotid/venous/AV access/EVAR

    Moderator:
    Stephan Duda
    Panel:
    Jean-Paul de Vries, Peter Huppert
    1. -

      PrOspective multiCentrE study of cArotid artery steNting using MER stent– the OCEANUS study – 30 days and one year follow-up

        Piotr Odrowaz-Pieniazek
    2. -

      PARADIGM-EXTEND prospective academic trial of CGuard™ MicroNET-covered self-expandable stent system: Cumulative 3-year clinical and duplex ultrasound evidence for safety, efficacy, and durability of stroke prevention

        Piotr Musialek
    3. -

      Double layer micromesh stents vs. closed cell stents for the endovascular treatment of carotid stenosis in the current era

        Paolo Righini
    4. -

      Intermediate results of a prospective randomized study in carotid artery revascularisation: the Acculink™ stent vs. the mesh covered stent (CGuard™)

        Pavel Ignatenko
    5. -

      Ad interim results from a prospective real-world multicentre clinical practice of CAS using the CGuard™ embolic prevention system: the IRONGUARD 2 study

        Wassim Mansour
    6. -

      Significant contrast dose-reduction with digital variance angiography in carotid and cerebral X-ray angiography

        Viktor Imre Óriás
    7. -

      Comparative analysis of carotid artery stenting and carotid endarterectomy in clinical practice

        Andrey Karpenko
    8. -

      Clinical evaluation on therapeutic efficacy of Angiojet Rheolytic thrombectomy in patients with acute pulmonary embolism

        Shuiting Zhai
    9. -

      Significant reduction in radiation using the 4 French instead of 6 French WavelinQ endoAVF system in creating endovascular AV-fistulas

        Tobias Steinke
    10. -

      Fully absorbable patch based large hole vascular closure device

        Daniela Branzan
    11. -

      2-year outcomes of EVAS and Ch-EVAS in abdominal aortic aneurysms based on calculated neck length: a single-center study

        Patrick Berg
    12. -

      Interim results from the PERFORMANCE I study – CAS using a 3-in-1 carotid artery stent system with an integrated embolic protection filter and post-dilation balloon

        Horst Sievert
    13. -

      Discussion

  • - , Scientific Posters

    Original research: AV-access, iliac, venous, and miscellaneous

    Juror:
    Robert Jones, Rick de Graaf
    1. -

      Safety and efficacy of covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for complex aortoiliac occlusive disease: a single center experience

        Stefano Molinaro
    2. -

      Time differentiation based image enhancement algorithms for kinetic imaging

        David Szollosi
    3. -

      6-month result from a double-blinded randomised control trial for DCB vs. plain balloon angioplasty for dysfunctional vascular access

        Skyi Yin Chun Pang
    4. -

      Longevity and infection free survival of permicath

        Mohamed Ismail
    5. -

      Permeability of viabahn covered stent in native fistulas for hemodialysis: does puncture influence its permeability?

        Pedro B. García-Jurado
    6. -

      Vein suturless anastomosis in vascular access graft

        Marco Franchin
    7. -

      Catheter directed thrombolytic therapy complemented by ECMO: Treatment of massive pulmonary embolism with cardiac arrest

        Mert Dumantepe
    8. -

      Long term follow up after endovenous thermal ablation and open surgery of varicose veins

        Beatrix Cucuruz
    9. -

      12-month clinical outcome of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis

        Tim Sebastian
    10. -

      Chronic Post-Thrombotic Syndrome – Can direct CTV be helpful in predicting inflow for venous reconstruction?

        Andreia Coelho
    11. -

      Popliteal vein entrapment as the cause of varicose veins

        Ayhan Senol
    12. -

      Catheter directed thrombolysis as a primary choice in the management of acute iliofemoral deep venous thrombosis

        Abdulrahman Salem
    13. -

      Comparative study between conventional surgery and radiofrequency ablation in treatment of varicose vein

        Mohamed Ismail
    14. -

      Surfacer system post-market, international registry demonstrates safe and effective performance

        Tobias Steinke
    15. -

      Endovascular management of arteriovenous malformation: Tips & tricks

        Hesham Sharafeldin
    16. -

      Early results of a randomised clinical trial of mechanochemical ablation vs. cyanoacrylate adhesive for the treatment of varicose veins (MOCCA)

        Amjad Belramman
    17. -

      Novel compliant stent with specific design for truncular venous malformations: results of a porcine model study

        Pierfrancesco Veroux
    18. -

      Thrombectomy devices in the treatment of massive acute pulmonary embolism: initial single center experience with aspirex and novel technique through jugular access

        Bruno Freitas
  • - , Room 5 - Global Expert Exchange

    CCT@LINC: Advanced endovascular therapy in Japan – Pre-recorded live cases

    Moderator:
    Giancarlo Biamino, Kazushi Urasawa
    Panel:
    Michinao Tan, Tatsuya Nakama, Hiroshi Ando
    1. -

      Video live and lecture: EVT for SFA in-stent reocclusion

        Michinao Tan
    2. -

      Video live and lecture: Aggressive below-the-ankle revascularisation

        Tatsuya Nakama
    3. -

      Video live and lecture: Techniques for severely calcified lesions

        Hiroshi Ando
    4. -

      Video live and lecture: Optimization of POBA for DCB

        Kazushi Urasawa
    5. -

      Discussion and conclusion

  • - , Room 1 - Main Arena 1

    Advanced solutions for complex femoral lesions and critical limb ischemia

    Moderator:
    John Laird, Marc Bosiers
    Panel:
    Jos van den Berg, Yann Gouëffic, Lawrence Garcia, Stefan Müller-Hülsbeck, Brian DeRubertis, Torsten Fuß
    1. -

      True minimally invasive access strategies for complex peripheral interventions

        Jos van den Berg
    2. -

      Live case transmission from Leipzig

        University Hospital Leipzig, Dep. Angiology - Live case center
    3. -

      First time data release: Can Legflow® improve treatment of long femoropopliteal lesions: the REFLOW outcomes

        Marc Bosiers
    4. -

      First time data release: Total IN.PACT™ 1-year results: Complex lesion outcomes from the IN.PACT study series

        Peter Schneider
    5. -

      IN.PACT Admiral DCB: a look at long lesion outcomes across trials

        Antonio Micari, Via satellite from Bergamo
    6. -

      From research to practice: how does atherectomy fit in my treatment algorithm

        Grigorios Korosoglou
    7. -

      Live case transmission from New York

        Mount Sinai Hospital New York - Live case center
    8. -

      REALITY: Initial experience

        Ravish Sachar
    9. -

      Phoenix atherectomy: technique and real-world evidence

        Miguel Montero-Baker
  • - , Room 2 - Main Arena 2

    Scrub-in with the experts: Endovascular therapy of chronic deep vein obstructions

    live from Zurich:
    Nils Kucher
    live from Galway:
    Gerard O'Sullivan
    Moderator:
    Stephen Black
    Panel:
    Michael Dake, Mahmood Razavi, Klaus Mathias, Tim Sebastian, Houman Jalaie

    1. Flash presentation: Endovascular techniques for difficult deep vein obstructions

        Stephen Black

    2. Flash presentation: Endophlebectomy plus stent vs. stent reconstruction alone for PTS patients with poor inflow vessels

        Houman Jalaie

    3. Flash presentation: Antithrombotic therapy following stent reconstruction for PTS: real word practice and the planned ARIVA trial

        Tim Sebastian
  • - , Room 3 - Technical Forum

    Scrub-in with the experts: Supraaortic and brachial interventions

    live from Bergamo:
    Fausto Castriota, Antonio Micari
    live from Leipzig:
    Andrej Schmidt
    Moderator:
    William Gray, Horst Sievert
    Panel:
    Sean Lyden, Bernhard Reimers, Stanislaw Bartus

    1. Flash presentation: Use of OCT and IVUS during CAS

        Bernhard Reimers

    2. Flash presentation: Comparison of Intravascular Ultrasound (IVUS) virtual histology during carotid artery stenting and lack of correlation with plaque embolization as measured by either clinical findings or the captured plaque observed on direct or flow-reversal filter

        Inkyong Parrack

    3. Flash presentation: Covered stents in the management of carotid artery erosion from head and neck cancers

        Michael Silva
Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

For more infos on the cookies we use and how you can manage them, please visit our cookie policy.

  • We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.